Program Overview
Please read the following information about this educational activity before accessing the presentations using links located at the bottom of this page.
| Program Released: March 19, 2007 | Review Date: January 14, 2010 Program Expires: March 1, 2011 |
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program provides 1 hour (0.1 CEU) of continuing education credit (program number 204-000-07-404-H01P).
Methods and Format
This is an online activity consisting of audio, slides, a post-test, and an activity evaluation tool. Participants must view the entire presentation, take the activity post-test, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time to complete this activity is 1 hour. This activity is provided free of charge.
Target Audience
This introductory continuing education activity was planned to meet the needs of practitioners, scientists, educators, administrators, and others committed to excellence in clinical pharmacy and patient pharmacotherapy. The program is beneficial for those who treat, instruct, or otherwise participate in the care of ambulatory and hospitalized patients with or at risk for venous thromboembolism.
Activity Content
Click here to view an overview of the activity content.
Learning Objectives
After participating in this knowledge-based educational activity, participants should be able to
- Describe the incidence and pathophysiology of venous thromboembolism (VTE).
- Identify patients at risk for the development of VTE.
- List non-pharmacologic and pharmacologic options for prophylaxis and treatment of VTE.
- Describe the mechanism of action of antithrombotic agents in VTE.
- Differentiate the dosing strategies for prophylaxis and treatment of VTE.
- List the common adverse effects and monitoring requirements of antithrombotic therapy in VTE.
Faculty
John Fanikos, M.B.A., R.Ph.
Assistant Director of Pharmacy
Brigham and Women’s Hospital
Assistant Professor of Clinical Pharmacy
Northeastern University
Massachusetts College of Pharmacy
Boston, Massachusetts
Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s and the Accreditation Council for Pharmacy Education's Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of program content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.
The faculty and planners report the following relationships:
John Fanikos, M.B.A., R.Ph.
Mr. Fanikos declares that he has served on the speakers bureau for Eisai Pharmaceuticals, GlaxoSmithKline, sanofi-aventis, Schering, and Genentech.
Kristi N. Hofer, Pharm.D.
Dr. Hofer declares that she has no relationships pertinent to this activity.
This activity is supported by an educational grant from sanofi-aventis, U.S.
Launch presentation*
Pharmacist Essentials in Preventing and Managing Venous Thromboembolism (55 minutes) *Allow additional time to complete the post-test and evaluation.
Download Post-Test
Click here to print the post-test for your reference. Please note that to be eligible for continuing education credit, you must go to the ASHP Learning Center and complete the test online.
